What is the prognosis and expected life span of a patient with aortic stenosis (Aortic Valve Stenosis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

The prognosis of aortic stenosis varies based on severity, but without treatment, severe aortic stenosis typically leads to death within 2-3 years after symptom onset, as stated in the 2016 study by 1.

Prognosis and Life Expectancy

The life expectancy of patients with aortic stenosis depends on the severity of the condition.

  • Mild aortic stenosis generally has minimal impact on life expectancy.
  • Moderate stenosis may progress over 2-5 years.
  • Severe aortic stenosis, if left untreated, can lead to death within 2-3 years after symptom onset.

Symptoms and Survival Rates

Once symptoms develop, such as:

  • Angina
  • Syncope
  • Heart failure survival rates decline significantly:
  • Average survival is 5 years with angina
  • 3 years with syncope
  • Only 2 years with heart failure symptoms

Treatment and Outcomes

Aortic valve replacement (surgical or transcatheter) dramatically improves outcomes, with post-procedure life expectancy approaching normal for many patients, as supported by the 2017 guideline update by 2.

Monitoring and Follow-up

Regular monitoring is essential, with echocardiograms recommended:

  • Every 6-12 months for severe stenosis
  • 1-2 years for moderate stenosis
  • 3-5 years for mild stenosis

Influencing Factors

Age, comorbidities, left ventricular function, and valve calcification also influence prognosis.

Medical Therapy

Medical therapy alone (including statins, ACE inhibitors, and careful blood pressure management) may slow progression but cannot reverse the mechanical obstruction of the valve, making valve replacement the definitive treatment for severe symptomatic aortic stenosis, as noted in the 2012 expert consensus document by 3.

From the Research

Prognosis of Aortic Stenosis

The prognosis of aortic stenosis (AS) varies depending on the severity of symptoms and treatment approach.

  • Asymptomatic patients with severe AS have a relatively benign prognosis, but survival decreases rapidly after symptoms appear 4.
  • Studies have shown that asymptomatic patients with severe AS who are advised against surgery have significantly higher mortality than patients who undergo aortic valve replacement 5, 6.
  • The probability of death at 1 year after recommendation was 5.2% in the watchful waiting group and 4.7% in the aortic valve replacement group 5.
  • Survival at 1,2, and 3 years for asymptomatic patients was 88%, 75%, and 63%, compared with 92%, 83%, and 78% in matched patients scheduled for aortic valve replacement 6.

Factors Affecting Prognosis

Several factors affect the prognosis of AS, including:

  • Severity of symptoms: Severe symptoms such as angina, syncope, or heart failure are associated with higher mortality 7.
  • Left ventricular ejection fraction (LVEF): Higher LVEF is associated with better survival 5, 8.
  • Renal failure: Renal failure is associated with worse survival 5.
  • Brain natriuretic peptide level: Lower brain natriuretic peptide level is associated with better survival 8.
  • Global longitudinal strain (GLS): Higher GLS is associated with better survival 8.

Treatment Approach

The treatment approach for AS depends on the severity of symptoms and surgical risk.

  • Aortic valve replacement is recommended for most symptomatic patients with evidence of significant AS on echocardiography 4.
  • Watchful waiting is recommended for most asymptomatic patients, but select patients may benefit from aortic valve replacement before the onset of symptoms 4.
  • Transcatheter aortic valve replacement may be considered in patients at high or prohibitive surgical risk 4.
  • Balloon aortic valvuloplasty (BAV) is used in high-risk patients with severe AS when the benefit of transcatheter aortic valve replacement or surgical aortic valve replacement is unclear 8.

Related Questions

In a 61-year-old asymptomatic male with concentric left ventricular hypertrophy, normal left ventricular size, normal ejection fraction, and severe aortic stenosis on echocardiography, and an unremarkable electrocardiogram showing left ventricular hypertrophy and normal sinus rhythm, what is the most appropriate next step in management?
In a 61-year-old man with concentric left-ventricular hypertrophy, severe aortic stenosis, a preserved ejection fraction of 60% and symptoms attributable to the valve lesion, what is the most appropriate next step in management?
In a 65-year-old man with exertional dyspnea, syncope, a harsh midsystolic murmur at the right upper sternal border radiating to the carotid arteries, cardiomegaly on chest X‑ray, and left ventricular hypertrophy on ECG, what is the most appropriate management?
What is the recommended management for a 76-year-old asymptomatic woman with mild cardiomegaly?
What is the most appropriate management for a 2‑month‑old infant with severe aortic stenosis (aortic valve gradient ≈60 mm Hg), preserved left ventricular systolic function, normal blood pressure and heart rate, and exertional dyspnea?
What are the contraindications for Guaifenesin (Mucinex)?
Why does tachycardia (high heart rate) associated with Postural Orthostatic Tachycardia Syndrome (POTS) improve at night?
What is the administration rate for intravenous (IV) metoprolol (Lopressor)?
What is the significance of portal hypertension with cirrhosis of the liver in a patient with normal liver function?
What is the diagnosis and treatment for necrotizing pancreatitis (inflammation of the pancreas with tissue death)?
What is the difference between autoimmune and autoinflammatory (Autoimmune: related to immune system disorders, Autoinflammatory: related to inflammatory disorders) diseases?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.